Nano Miscellaneous

Astal Laboratories Ltd.

ASTALLTD

Market Cap
₹360 Cr.
P/E
44.37

Astal Laboratories Ltd.

  • Astal Laboratories
  • Swiss Military Cons.
  • Rotographics (India)

FAQs on Astal Laboratories Ltd. Shareprice

Astal Laboratories has given lower returns compared to its competitors.
Astal Laboratories has grown at ~28.86% over the last 4yrs while peers have grown at a median rate of 68.8%

Astal Laboratories is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Astal Laboratories is 44.37, while 3 year average PE is 87.52.
Also latest EV/EBITDA of Astal Laboratories is 19.63 while 3yr average is 9.03.

View FAQ's On Business

Growth Table

  • Astal Laboratories Ltd.
  • Swiss Military Cons.
  • Rotographics (India)

Balance Sheet

  • Astal Laboratories Ltd.
  • Swiss Military Cons.
  • Rotographics (India)

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Astal Laboratories Ltd.
  • Swiss Military Cons.
  • Rotographics (India)

Cash Flow

  • Astal Laboratories Ltd.
  • Swiss Military Cons.
  • Rotographics (India)

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Astal Laboratories Ltd.
  • Swiss Military Cons.
  • Rotographics (India)

Quarterly Results

  • Astal Laboratories Ltd.
  • Swiss Military Cons.
  • Rotographics (India)

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Astal Laboratories Ltd. Financials

Balance sheet of Astal Laboratories is moderately strong.

Yes, The net debt of Astal Laboratories is increasing.
Latest net debt of Astal Laboratories is ₹47.78 Crs as of Mar-26.
This is greater than Mar-25 when it was ₹9.81 Crs.

The profit is oscillating.
The profit of Astal Laboratories is ₹8.12 Crs for TTM, ₹8.93 Crs for Mar 2025 and ₹0.78 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Astal Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech